期刊文献+

双表达外源性4-1BBL/RANTES的K562细胞活化外周血淋巴细胞的研究

Activation of Peripheral Blood Lymphocytes Stimulated by Modified K562 Cells Expressing Exogenous 4-1 BBL and RANTES
下载PDF
导出
摘要 目的探讨K562细胞表达外源性蛋白4-1BBL/RANTES后,对T细胞、NK细胞有无活化作用,为进一步构建人工抗原提呈细胞提供前提。方法采用分子克隆技术,分别将4-1BBL和RANTES基因插入双表达载体pVITRO-2,命名为pV4-1BBL-RANTES。经测序鉴定后,利用脂质体介导的转染及潮霉素筛选,获得稳定双表达4-1BBL、RANTES分子的K562细胞(K562/4-1BBL/RANTES)。经流式细胞仪(FACS)分选后,K562/4-1BBL/RANTES细胞用丝裂霉素C处理,与外周血淋巴细胞孵育24,FACS检测淋巴细胞表面活化性受体CD69的表达;对NK细胞同时检测了活化性受体NKG2D的表达情况。结果受K562/4-1BBL/RANTES细胞刺激后,CD3+T细胞、CD4+T细胞、γδT细胞和NK细胞的活化性受体CD69的表达与未受刺激前相比,均有明显上调;但与单纯K562细胞刺激组相比,无显著差异。另外,CD8+T细胞CD69的表达及NK细胞NKG2D的表达无明显变化。结论将4-1BBL和RANTES共表达于K562细胞,不具备活化淋巴细胞的效应。 Objective To observe whether modified K562 cells double expressing exogenous 4-1BBL and RANTES can stimulate peripheral blood lymphocytes. Methods Human 4-1bbl and RANTES eDNA gene were introduced into respective multi-cloning sites of the double expression eukaryotie veetor-pVITRO-2 with the recombinant DNA technique. After identification by DNA sequencing analysis, stable expression of exogenous 4-1BBL and RANTES in K562 cells were carried out through transfeetion mediated by liposome. Under the selection of hygromyein B, 4-1BBL expression was confirmed by flow eytometery and RANTES expression by RT-PCR. After being sorted by flow cytometery, the modified K562 cells were treated by mitomycin C before co-cultured with peripheral blood lymphocytes for about 24 hours. Expression of activating receptor (CD69) on T cells, γδT cells, and CD69, NKG2D receptors on NK cells were detected by flow eytometery. Results After having being co-cultured with K562/4-1BBL/RANTES cells, CD3^+T cell,CD4^+T cell, γδT cell and NK cell had up - regulated CD69 expression. However , there were not significant differences of expressi on of CD69 on the surface of above lymphoctes in comparison with stimulation by original K562 cells. Furthermore, expression of CD69 on CD8 ^+ T cells and NKG2D on NK cell had no significant variation compared with no-stimulation and stimulation from original K562 cells. Conclusions Modified K562 cells with co-expression of 4-1BBL and RANTES could not activate T cell and NK cell.
出处 《实用临床医药杂志》 CAS 2007年第4期29-34,共6页 Journal of Clinical Medicine in Practice
基金 国家自然科学基金资助项目(30400399) 江苏省自然科学基金资助项目(BK2004404) 江苏省高校自然科学基金资助项目(04KJB320162)
关键词 4-1BBL RANTES K562 表达 活化 4-1BBL RANTES K562 expression activation
  • 相关文献

参考文献15

  • 1Hermans I F, A Dash J, Yang D S, et al. Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-speciflc cytotoxic T lymphocyte precursors [J ]. Cancer research, 1998, 58: 3909.
  • 2Albertsson P A, Basse P H, Hokland M, et al. NK cells and the tumor microenvironment : implications for NK-cell function and anti-tumor activity[J]. Trends in Immunol, 2003, 24 : 603.
  • 3Ho W Y, Blattman J N, Dossett M L, et al. Adoptive immunotherapy: Engineering T cell responses asbiologic weapons for tumor mass destruction[J]. Cancer Cell, 2003, 3 : 431.
  • 4Lee H W, Park S J, Choi B K, et al. 4-1BB promotes the survival of CD8^+ T lymphocytes by increasing expression of Bcl-XL and Bfl-1[J]. J Immunol, 2002, 168: 3777.
  • 5Appay V, Rowland-Jones S L. RANTES: a versatile and controversial chemokine[J]. Trends in Immunology, 2001, 22 : 83.
  • 6Maus M V, Thomas A K, Leonard D G, et al. Ex vivo expansion of polyclonal and antigen-specific cytotoxic T lymphocytes by artificial APCs expressing ligands for the T-cell receptor, CD28 and 4-1BB[J]. Nat Biotechnol, 2002, 20: 143.
  • 7Schwarz H, Valbracht J, Tuckwell J, et al. ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineges[J]. Blood, 1995, 85: 1043.
  • 8Nam K O, Kang W J, Keon B S, et al. The therapeutic potential of 4-1BB(CD147) in cancer[J ]. Current Cancer Drug Targets, 2005, 5: 357.
  • 9Cheuk A T, Mufti G J, Guinn B. Role of 4-1BB:4-1BB ligand in cancer immunotherapy [ J ]. Cancer Gene Therapy, 2004, 11: 215.
  • 10Melero I, Bach N, Hellsmm K E, et al. Amplification of tumor immunity lay gene transfer of the co-stimulatory 4-1BB ligand: synergy with the CD28 co-stimulatory pathway[J]. Eur J Immunol, 1998, 28: 1116.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部